• Jennifer Thomas, PhD: ARFID Is More Than Picky Eating—And the Condition Is on the Rise (Scientific American)

    Jennifer Thomas, PhD: ARFID Is More Than Picky Eating—And the Condition Is on the Rise (Scientific American)0

    Avoidant/Restrictive Food Intake Disorder or ARFID was formally included as a distinct diagnosis in the DSM-5 in 2013, marking a pivotal shift in how clinicians and researchers understand and approach restrictive eating behaviors across the lifespan.  While there has been a recent rise in ARFID diagnoses, reflecting growing awareness of the disorder, there remains a

    READ MORE
  • ACIP hep b vaccine, FDA drug vouchers: Morning Rounds

    ACIP hep b vaccine, FDA drug vouchers: Morning Rounds0

    Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Happy Friday! I hope you’re having a better day than the 531 patients in Maine and New Hampshire who mistakenly received letters confirming their death.  We’ve also got some juicy details regarding Thursday’s big GLP-1 announcement. Let’s

    READ MORE
  • Trump Unveils Deal to Cover and Lower Costs on Obesity Drugs

    Trump Unveils Deal to Cover and Lower Costs on Obesity Drugs0

    WASHINGTON (AP)—President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy. The drugs are part of a new generation of obesity medications known as GLP-1 receptor agonists that have soared in popularity in recent years. But access

    READ MORE
  • Iowa to pay $600,000 to former public health spokesperson who claimed wrongful firing

    Iowa to pay $600,000 to former public health spokesperson who claimed wrongful firing0

    This story was updated at 8:55 p.m. on Wednesday, Nov. 5 to include a statement from the governor’s office. The state of Iowa will pay $600,000 to settle a wrongful termination lawsuit brought by a former communications director for the Iowa Department of Public Health (IDPH), who claimed she was forced to resign for attempting

    READ MORE
  • Faculty Spotlight: Lisa Hightow-Weidman advances public health through digital platforms

    Faculty Spotlight: Lisa Hightow-Weidman advances public health through digital platforms0

    Hightow-Weidman became a pioneer in digital health research, demonstrating that web and mobile-based interventions could reduce HIV risk behaviors and improve care. She created several digital health platforms that promote HIV prevention in innovative ways.  For example, through partnerships with organizations like the National Institute of Health (NIH), Hightow-Weidman accelerated the commercialization and scalability of digital health with the platform HealthMPowerment (HMP) that bridged academic discovery with real-world impact. Optimized for mobile use, HMP addresses a

    READ MORE
  • Taper Use of GLP-1 Drugs with a Measured Approach

    Taper Use of GLP-1 Drugs with a Measured Approach0

    The success of GLP-1 drugs like Ozempic, Wegovy and Mounjaro is clear as relates to their impact on safe weight loss. For many people, weaning themselves off these breakthrough drugs is less clear, a ThedaCare obesity medicine expert said. GLP-1s were designed to help manage blood sugar and glucose levels in people with type 2

    READ MORE
css.php